Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Carrillo, F., Sigman, M., Slezak, D. F., Ashton, P., Fitzgerald, L., Stroud, J., ... & Carhart-Harris, R. L. | Journal of affective disorders | 30 March 2018
Four weekly ayahuasca sessions lead to increases in “acceptance” capacities: a comparison study with a standard 8-week mindfulness training program
Soler, J., Elices, M., Dominguez-Clave, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., ... & Riba, J. | Frontiers in Pharmacology | 20 March 2018
Role of the 5-HT2A receptor in self- and other-initiated social interaction in LSD-induced states – a pharmacological fMRI study
Preller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. | Journal of Neuroscience | 19 March 2018
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M. C., Lorusso, M., ... & Lerner, A. G. | Brain sciences | 16 March 2018
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. | Handbook of Experimental Pharmacology | 13 March 2018
The entropic brain – Revisited
Carhart-Harris, R. L. | Neuropharmacology | 13 March 2018
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. | Behavioural pharmacology | 13 March 2018
Acute pharmacological effects of 2C-B in humans: An observational study
Papaseit, E., Farré, M., Perez-Maña, C., Torrens, M., Ventura, M., Pujadas, M., ... & González, D. | Frontiers in Pharmacology | 13 March 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia, A. A., & Mithoefer, M. C. | Progress in neuro-psychopharmacology and biological psychiatry | 7 March 2018
Altered network hub connectivity after acute LSD administration
Müller, F., Dolder, P. C., Schmidt, A., Liechti, M. E., & Borgwardt, S. | NeuroImage: Clinical | 7 March 2018
The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity
Hartogsohn, I. | Frontiers in neuroscience | 6 March 2018
Unifying Theories of Psychedelic Drug Effects
Swanson, L. R. | Frontiers in Pharmacology | 2 March 2018
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
Schindler, E. A. D., Wallace, R. M., Sloshower, J. A., & D'Souza, D. C. | Frontiers in pharmacology | 1 March 2018
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)
Nichols, D. E. | ACS chemical neuroscience | 1 March 2018
The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
Nielson, E. M., May, D. G., Forcehimes, A. A., & Bogenschutz, M. P. | Frontiers in Pharmacology | 21 February 2018
Psychedelics: Where we are now, why we got here, what we must do
Belouin, S. J., & Henningfield, J. E. | Neuropharmacology | 21 February 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Ionescu, D. F., Felicione, J. M., Gosai, A., Cusin, C., Shin, P., Shapero, B. G., & Deckersbach, T. | Harvard review of psychiatry | 20 February 2018
The re-emergence of hallucinogenic research
Begola, M. J., & Dowben, J. S. | Perspectives in psychiatric care | 20 February 2018
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
Bogenschutz, M. P., Podrebarac, S. K., Duane, J. H., Amegadzie, S. S., Malone, T. C., Owens, L. T., ... & Mennenga, S. E. | Frontiers in Pharmacology | 20 February 2018
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Niciu, M. J., Shovestul, B. J., Jaso, B. A., Farmer, C., Luckenbaugh, D. A., Brutsche, N. E., ... & Zarate, C. A. | Journal of affective disorders | 17 February 2018
Powerful substances in tiny amounts An interview study of psychedelic microdosing
Johnstad, P. G. | Nordic Studies on Alcohol and Drugs | 15 February 2018
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. | Nature | 14 February 2018
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation
Curran, H. V., Nutt, D., & de Wit, H. | Psychopharmacology | 14 February 2018
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018